Editas Medicine
EDIT
$5.47
Share price
4.99%
Change (1 day)
-34.10%
Change (1 year)
EPS for Editas Medicine (EDIT)
EPS in 2023 (TTM): -$2.96
According to Editas Medicine 's latest financial reports the company's current EPS (TTM) is -$2.96. In 2022 the company made an earnings per share (EPS) of -$3.21 a decrease over its 2021 EPS that were of -$2.85.
EPS history for Editas Medicine from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.96 | -7.79% |
| 2022 | -$3.21 | 12.63% |
| 2021 | -$2.85 | 43.22% |
| 2020 | -$1.99 | -26.02% |
| 2019 | -$2.69 | 15.45% |
| 2018 | -$2.33 | -21.81% |
| 2017 | -$2.98 | -1.65% |
| 2016 | -$3.03 | -29.19% |
| 2015 | -$4.28 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -$2.06 | -30.41% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -$6.20 | 109.46% | 🇬🇧 UK |
 Novavax NVAX | -$7.19 | 142.91% | 🇺🇸 USA |
 Novocure
NVCR | -$1.86 | -37.16% | Jersey |